Skip to content
Logo text: ISPOR Improving healthcare decisions

Health Technology Assessment Central

The HTA Resource Center for Informing Healthcare Decisions

  • Home
  • What Is HTA?
  • HTA News and Events
  • Resource Library
  • Governance
  • Policy Interchange
  • Training and Development
« Back to ISPOR.org

News

Novartis first to benefit from NICE advice on ‘patient preference’

February 18, 2019

http://www.pmlive.com/pharma_news/novartis_first_to_benefit_from_nice_advice_on_patient_preference_1278304

Posted in: Uncategorized

Post navigation

← NICE collaborates with the Canadian Agency for Drugs and Technology in Health to offer parallel scientific advice
UHC Act: The role of Health Technology →

News

Dr. Brian O’Rourke to Retire as CADTH’s President and CEO
MOH inaugurates Steering and Technical committees for Health Technology Assessment
Sir Andrew Dillon to stand down as NICE chief executive
INAHTA welcomes NICE, UK as newest member
INAHTA welcomes SEC, Ukraine, as Candidate Member
HIQA signs memorandum of understanding to support health technology assessment in Ireland, Scotland and Wales
Growing Patient Involvement in Health Technology Assessment (HTA)
NICE launches online resource to help development and adoption of new health technologies
CADTH Celebrates Health Technology Assessment Leaders
Canada to create national drug agency to help cut cost of medicines

Twitter

Tweets about #HTA

#HTA

LizaEskanderLiza R. Eskander✨@LizaEskander·
4h

Very informative and interesting conference..
#ISPOR #HTA #HTAOFFICE #PHAMACOECONOMICS #healtheconomics #publichealth #FDA #WHO @GihanElsisi @ISPORorg

2
Reply on Twitter 1186046358681194499Retweet on Twitter 1186046358681194499Like on Twitter 1186046358681194499Twitter 1186046358681194499
KMFaceyKaren Facey@KMFacey·
10h

Good animation explaining EQ5D - it would be great to see a sequel from #HTA explaining how utilities are then calculated

Reply on Twitter 1185957210645565440Retweet on Twitter 1185957210645565440Like on Twitter 1185957210645565440Twitter 1185957210645565440
joseajarneJosé Á. Jarne@joseajarne·
16h

#HTA #ECV

Reply on Twitter 1185865015255097344Retweet on Twitter 1185865015255097344Like on Twitter 1185865015255097344Twitter 1185865015255097344
Load More...
Privacy Policy | Disclaimer
Copyright © 2019 ISPOR – The Professional Society for Health Economics and Outcomes Research